Breast Cancer Models
PDF
Cite
Share
Request
Review
P: 30-39
March 2019

Breast Cancer Models

Nucl Med Semin 2019;5(1):30-39
1. Trakya Üniversitesi Tıp Fakültesi, Nükleer Tıp Anabilim Dalı, Edirne, Türkiye
No information available.
No information available
Publish Date: 03.04.2019
PDF
Cite
Share
Request

ABSTRACT

Breast cancer is the most common cancer in women. 11.5% of breast cancer patients are at distant stage and mortality is due to metastases rather than primary disease. Experimental breast cancer tumor models are validated methods to examine the pathogenesis of cancer, the onset of the neoplastic process, and progression. The development of animal models for breast cancer research has been conducted in the last century. Imaging methods in breast cancer are used for tumor localization, quantification of tumor mass, imaging of genes and proteins, evaluation of tumor microenvironment, evaluation of tumor cell proliferation and metabolism, and treatment response evaluation. Since human breast cancer is a heterogeneous group of diseases in terms of genetics and phenotype, it is not possible for a single model to adequately address all aspects of breast cancer biology. Considering that each model has advantages and disadvantages compared to each other, the most suitable model should be chosen in order to verify the thesis of the study.

References

1Kara F, İlter E, Keskinkılıç B. Türkiye kanser istatistikleri 2015. Ankara: Halk Sağlığı Genel Müdürlüğü, Sağlık Bakanlığı; 2018.
2Whittle JR, Lewis MT, Lindeman GJ, Visvader JE. Patient-derived xenograft models of breast cancer and their predictive power. Breast Cancer Res 2015;17:17.
3Heppner GH, Miller FR, Shekhar PM. Nontransgenic models of breast cancer. Breast Cancer Res 2000;2:331-334.
4Manning HC, Buck JR, Cook RS. Mouse models of breast cancer: platforms for discovering precision imaging diagnostics and future cancer medicine. J Nucl Med 2016;57:60-68.
5Clarke R. Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 1996;39:1-6.
6Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996;39:7-20.
7Ustun F, Durmus-Altun G, Altaner S, Tuncbilek N, Uzal C, Berkarda S. Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC. Med Oncol 2011;28:1264-1272.
8Ustun F, Durmus-Altun G, Cukur Z, Altaner S, Berkarda S. Glucose-induced alteration of accumulation of organotechnetium complexes accumulation in Pgp-negative tumor-bearing mice. Cancer Biother Radiopharm 2009;24:333-338.
9Chen MT, Sun HF, Zhao Y, et al. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep 2017;7:9254.
10Price JE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 1996;39:93-102.
11Sierra A. Animal models of breast cancer for the study of pathogenesis and therapeutic insights. Clin Transl Oncol 2009;11:721-727.
12Khanna C, Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005;26:513-523.
13Kiessling F, Pichler BJ. Small Animal Imaging Basics and Practical Guide. Berlin Heidelberg: Springer-Verlag; 2011. p. 543-564.
14Zanzonico P. Noninvasive Imaging for Supporting Basic Research. In: Kiessling F, Pichler BJ, editors. Small Animal Imaging Basics and Practical Guide. Berlin Heidelberg: Springer-Verlag; 2011. p. 3-16.
15Kiessling F, Pichler BJ, Hauff P. How to Choose the Right Imaging Modality. In: Kiessling F, Pichler BJ, editors. Small Animal Imaging Basics and Practical Guide. Berlin Heidelberg: Springer-Verlag; 2011. p. 119-124.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House